Astellas Pharma and AstraZeneca are joining Bristol Myers Squibb by deploying Evinova’s artificial-intelligence-native platform in an effort to speed up clinical development.

Modella AI, a leader in artificial intelligence for life sciences, today announced that it has been acquired by AstraZeneca, expanding the companies’ existing collaboration to advance the application ...

Ltd., in collaboration with the public and private sectors, academia, and patient networks, has officially launched the A.Catalyst Network Thailand Hub. This global health innovation network aims to ...

High performance networking company Ericsson has joined biopharmaceutical company AstraZeneca, Saab, SEB Bank and Wallenberg Investments to launch Sferical AI, Linköping, Sweden, which aims to ...